Get the Stockscreener App
90.29
0.94%
0.84
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Wells Fargo Co stock is traded at $90.29, with a volume of 12.90M.
It is up +0.94% in the last 24 hours and up +3.25% over the past month.
Wells Fargo is a premier, North American-focused banking titan that commands a $2.2 trillion balance sheet and the third-highest deposit market share in the United States. The bank uses a dense, expansive network of 4,093 branches to champion retail consumers and the middle market, where the firm has built a particularly strong reputation. Following the removal of its federal asset cap in 2025, the firm is set to deploy its legacy excess liquidity to expand each of its four segments: consumer & business lending, commercial banking, corporate & investment banking, and wealth & investment management.
See More
Previous Close:
$89.45
Open:
$90.74
24h Volume:
12.90M
Relative Volume:
0.94
Market Cap:
$273.04B
Revenue:
$128.92B
Net Income/Loss:
$22.97B
P/E Ratio:
13.12
EPS:
6.8796
Net Cash Flow:
$-2.35B
1W Performance:
+0.36%
1M Performance:
+3.25%
6M Performance:
+17.44%
1Y Performance:
+11.13%
1-Day Range:
$89.75
$91.16
1-Week Range:
$87.20
$91.16
52-Week Range:
$72.78
$97.76
Wells Fargo Co Stock (WFC) Company Profile
Name
Wells Fargo Co
Sector
Industry
Phone
(800) 869-3557
Address
333 MARKET STREET, SAN FRANCISCO, CA
Compare WFC vs JPM, BAC, HSBC, RY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WFC
Wells Fargo Co
|
90.29 | 273.04B | 128.92B | 22.97B | -2.35B | 6.8796 |
JPM
Jpmorgan Chase Co
|
356.23 | 946.93B | 297.42B | 64.78B | 148.32B | 23.34 |
BAC
Bank Of America Corp
|
62.69 | 438.38B | 194.43B | 33.77B | 64.54B | 4.3483 |
HSBC
Hsbc Holdings Plc Adr
|
105.30 | 360.63B | 133.80B | 21.76B | 105.99B | 6.0511 |
RY
Royal Bank Of Canada
|
205.90 | 285.05B | 99.69B | 16.04B | 26.84B | 11.15 |
Wells Fargo Co Stock (WFC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Upgrade | HSBC Securities | Hold → Buy |
| Mar-26-26 | Initiated | Jefferies | Buy |
| Feb-13-26 | Upgrade | Robert W. Baird | Underperform → Neutral |
| Jan-06-26 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Sep-29-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-25 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| May-15-25 | Initiated | TD Cowen | Hold |
| Apr-08-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-13-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-08-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-06-24 | Reiterated | Evercore ISI | Outperform |
| Sep-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-09-24 | Downgrade | Compass Point | Buy → Neutral |
| Mar-27-24 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-18-24 | Downgrade | Odeon | Buy → Hold |
| Jan-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-08-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-14-23 | Upgrade | Odeon | Hold → Buy |
| Sep-07-23 | Initiated | HSBC Securities | Hold |
| Jul-17-23 | Downgrade | Odeon | Buy → Hold |
| Jul-07-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-03-23 | Reiterated | Raymond James | Strong Buy |
| Jun-08-23 | Downgrade | Odeon | Buy → Hold |
| Apr-06-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-13-23 | Downgrade | Odeon | Buy → Hold |
| Jan-17-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-17-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-10-23 | Upgrade | Odeon | Hold → Buy |
| Oct-03-22 | Upgrade | Goldman | Neutral → Buy |
| Apr-11-22 | Upgrade | Citigroup | Neutral → Buy |
| Feb-01-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-12-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-03-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-10-21 | Resumed | UBS | Buy |
| Dec-06-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-29-21 | Upgrade | Odeon | Hold → Buy |
| Sep-28-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-19-21 | Downgrade | Odeon | Buy → Hold |
| Jul-15-21 | Upgrade | Odeon | Hold → Buy |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-04-21 | Upgrade | BofA Securities | Neutral → Buy |
| May-19-21 | Downgrade | UBS | Buy → Neutral |
| Feb-18-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-19-21 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jan-12-21 | Upgrade | UBS | Neutral → Buy |
| Jan-07-21 | Upgrade | Jefferies | Hold → Buy |
| Dec-29-20 | Reiterated | Raymond James | Outperform |
| Dec-15-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-30-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-30-20 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Nov-24-20 | Upgrade | Raymond James | Underperform → Outperform |
| Nov-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-06-20 | Upgrade | Compass Point | Neutral → Buy |
| Sep-14-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-11-20 | Upgrade | UBS | Sell → Neutral |
| Sep-02-20 | Upgrade | Odeon | Hold → Buy |
| Jul-22-20 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Jul-15-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-10-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-09-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jul-08-20 | Initiated | Seaport Global Securities | Neutral |
| Jun-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-29-20 | Initiated | DA Davidson | Neutral |
| May-05-20 | Downgrade | Atlantic Equities | Neutral → Underweight |
| May-04-20 | Downgrade | UBS | Neutral → Sell |
| Apr-14-20 | Initiated | Compass Point | Neutral |
| Mar-26-20 | Upgrade | Odeon | Sell → Hold |
View All
Wells Fargo Co Stock (WFC) Latest News
Is Wells Fargo (NYSE:WFC) Still Undervalued After Its Big Run? - Kalkine Media
Wells Fargo (WFC) Stock Could Be 27% Undervalued Following Interest Rate Warning - simplywall.st
CLX Maintains Rating by Wells Fargo -- Price Target Lowered to $90 - GuruFocus
Wells Fargo & Company Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price - MarketBeat
What is moving Wells Fargo (NYSE:WFC) shares in today's market? - Kalkine Media
Wells Fargo raises TE Connectivity price target on power content gains - Investing.com
Wells Fargo cuts Restoration Hardware stock price target on margin pressure - Investing.com
Wells Fargo raises Adobe stock price target on enterprise growth - Investing.com
Wells Fargo raises Adobe stock price target on enterprise growth By Investing.com - Investing.com UK
Wells Fargo & Co CEO warns that the Clarity Act could harm the financial system? - 富途牛牛
Wells Fargo initiates Bread Financial stock with $115 target - Investing.com
Wells Fargo Adjusts Price Target on TE Connectivity to $220 From $209, Keeps Equalweight Rating - marketscreener.com
Wells Fargo & Co. stock gains support as Goldman Sachs sticks with Buy rating - ad-hoc-news.de
Wells Fargo Share Price Today (WFC) | Live Chart, News & Stock Market - TechGraph
Wells Fargo analyst sees deepening troubles for Western brands in China - Investing.com Canada
Wells Fargo stock heads into the open after a 0.8 percent pullback - ad-hoc-news.de
What to Know as Wells Fargo Upgrades Synopsys Stock - Barchart.com
Wells Fargo (NYSE:WFC) Moves With Financial Sector As Yield Curve Steepens - Kalkine Media
Wells Fargo & Company Issues Pessimistic Forecast for Kimberly-Clark (NASDAQ:KMB) Stock Price - MarketBeat
Wells Fargo & Co. stock gains as Goldman Sachs lifts price target to USD 111 - ad-hoc-news.de
Wells Fargo expands neurodiversity hiring program as banking industry pulls back on DEI - The Business Journals
Wells Fargo continues longstanding partnership with Thurgood Marshall College Fund through presenting sponsorship of 2026 Leadership Institute - Thurgood Marshall College Fund, Inc.
Wells Fargo resolves trading outage tied to processing firm - Citywire
OPKO Health at Wells Fargo conference: cash-rich pivot to therapeutics - Investing.com
Spyre Therapeutics at Wells Fargo conference: betting on combination biologics - Investing.com Canada
Disc Medicine at Wells Fargo conference: two drug bets near key tests - Investing.com
Eagle Materials (NYSE:EXP) Downgraded by Wells Fargo & Company to Hold - MarketBeat
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’ - Benzinga
Wells Fargo cuts Cooper Companies stock price target on guidance miss - Investing.com Canada
Wells Fargo cuts Kimberly-Clark stock price target on earnings concerns - Investing.com
Wells Fargo cuts AutoZone stock price target on earnings concerns - Investing.com
Wells Fargo upgrades Yum! Brands stock rating on growth outlook - Investing.com
Wells Fargo cuts AutoZone stock price target on earnings concerns By Investing.com - Investing.com UK
Wells Fargo upgrades Yum! Brands stock rating on growth outlook By Investing.com - Investing.com India
Wells Fargo raises RXO stock price target on brokerage momentum By Investing.com - Investing.com India
WINTON GROUP Ltd Acquires New Holdings in Wells Fargo & Company $WFC - MarketBeat
Wells Fargo cuts Core & Main stock price target on margin concerns - Investing.com Canada
Wells Fargo cuts Casey’s General Stores price target on valuation By Investing.com - Investing.com Canada
Wells Fargo raises Pyxis Oncology stock price target on MICVO data - Investing.com India
Wells Fargo raises Signet Jewelers stock price target on credit deal - Investing.com UK
Wells Fargo raises Academy Sports stock price target on diversified product mix - Investing.com India
Pharvaris at Wells Fargo conference: oral HAE drug gains ground By Investing.com - Investing.com Nigeria
ORIC Pharmaceuticals at Wells Fargo conference: late-stage pipeline in focus - Investing.com India
Halozyme at Wells Fargo healthcare conference: subQ push gains steam By Investing.com - Investing.com Canada
Climb Bio at Wells Fargo conference: two antibody bets draw focus - Investing.com India
Halozyme at Wells Fargo healthcare conference: subQ push gains steam - Investing.com
Rhythm Pharmaceuticals at Wells Fargo conference: ho launch gains traction - Investing.com
ThredUp to Participate in Goldman Sachs and Wells Fargo Conferences - globenewswire.com
AptarGroup at Wells Fargo healthcare conference: execution takes center stage - Investing.com
UnitedHealth Group (NYSE: UNH) Shares Strategic Insights and Performance at Wells Fargo Healthcare Conference - Kalkine Media
Becton, Dickinson at Wells Fargo healthcare conference: focus sharpens - Investing.com
Wells Fargo Co Stock (WFC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.58%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):